These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11837905)

  • 41. Subunit vaccines for the control of tick-borne diseases: implications for the future.
    Musoke AJ; McKeever D; Nene V
    Parassitologia; 1997 Jun; 39(2):131-7. PubMed ID: 9530697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccination of older Bos taurus bulls against bovine babesiosis.
    Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
    Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Babesia bigemina, Babesia argentina, and Anaplasma marginale: Coinfectious immunity in bovines.
    Todorovic RA; Gonzalez EF; Adams LG
    Exp Parasitol; 1975 Apr; 37(2):179-92. PubMed ID: 1123013
    [No Abstract]   [Full Text] [Related]  

  • 44. Tick-borne diseases of cattle in Paraguay. I. Seroepidemiological studies on anaplasmosis and babesiosis.
    Payne RC; Osorio O
    Trop Anim Health Prod; 1990 Feb; 22(1):53-60. PubMed ID: 2321261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence of Babesia bovis, B. bigemina, Trypanosoma evansi, and Anaplasma marginale antibodies in cattle in southern Egypt.
    Fereig RM; Mohamed SGA; Mahmoud HYAH; AbouLaila MR; Guswanto A; Nguyen TT; Ahmed Mohamed AE; Inoue N; Igarashi I; Nishikawa Y
    Ticks Tick Borne Dis; 2017 Jan; 8(1):125-131. PubMed ID: 27789159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe.
    Turton JA; Katsande TC; Matingo MB; Jorgensen WK; Ushewokunze-Obatolu U; Dalgliesh RJ
    Onderstepoort J Vet Res; 1998 Jun; 65(2):81-6. PubMed ID: 9741051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular detection and genetic diversity of bovine Babesia spp., Theileria orientalis, and Anaplasma marginale in beef cattle in Thailand.
    Jirapattharasate C; Adjou Moumouni PF; Cao S; Iguchi A; Liu M; Wang G; Zhou M; Vudriko P; Efstratiou A; Changbunjong T; Sungpradit S; Ratanakorn P; Moonarmart W; Sedwisai P; Weluwanarak T; Wongsawang W; Suzuki H; Xuan X
    Parasitol Res; 2017 Feb; 116(2):751-762. PubMed ID: 28028631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Live vaccines against bovine babesiosis.
    de Waal DT; Combrink MP
    Vet Parasitol; 2006 May; 138(1-2):88-96. PubMed ID: 16504404
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transplacental transmission of bovine tick-borne pathogens: Frequency, co-infections and fatal neonatal anaplasmosis in a region of enzootic stability in the northeast of Brazil.
    Costa SC; de Magalhães VC; de Oliveira UV; Carvalho FS; de Almeida CP; Machado RZ; Munhoz AD
    Ticks Tick Borne Dis; 2016 Mar; 7(2):270-5. PubMed ID: 26613663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of an immunodominant 40 kDa merozoite antigen common to the Australian T and Dixie vaccine strains of Babesia bovis and the development of diagnostic tests specific for these strains.
    Molloy JB; Waldron SJ; Jorgensen WK
    Vet Parasitol; 1995 Dec; 60(3-4):229-40. PubMed ID: 8747906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spatial and management factors associated with exposure of smallholder dairy cattle in Tanzania to tick-borne pathogens.
    Swai ES; French NP; Karimuribo ED; Fitzpatrick JL; Bryant MJ; Brown PE; Ogden NH
    Int J Parasitol; 2005 Sep; 35(10):1085-96. PubMed ID: 16023121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serological survey of Babesia bovis, Babesia bigemina, and Anaplasma marginale antibodies in cattle from the semi-arid region of the state of Bahia, Brazil, by enzyme-linked immunosorbent assays.
    Barros SL; Madruga CR; Araújo FR; Menk CF; de Almeida MA; Melo EP; Kessler RH
    Mem Inst Oswaldo Cruz; 2005 Oct; 100(6):513-7. PubMed ID: 16302060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on failure of T strain live Babesia bovis vaccine.
    Bock RE; de Vos AJ; Lew A; Kingston TG; Fraser IR
    Aust Vet J; 1995 Aug; 72(8):296-300. PubMed ID: 8579560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bovine anaplasmosis and babesiosis in the Lesser Antilles: risk assessment of an unstable epidemiologic situation.
    Camus E; Montenegro-James S
    Vet Res; 1994; 25(2-3):313-7. PubMed ID: 8038806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated tick and tick-borne disease control trials in crossbred dairy cattle in Malawi.
    Lawrence JA; Musisi FL; Mfitilodze MW; Tjornehoj K; Whiteland AP; Kafuwa PT; Chamambala KE
    Trop Anim Health Prod; 1996 Nov; 28(4):280-8. PubMed ID: 8983132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
    Brown WC; Palmer GH
    Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a highly infective Babesia bigemina vaccine of reduced virulence.
    Dalgliesh RJ; Callow LL; Mellors LT; McGregor W
    Aust Vet J; 1981 Jan; 57(1):8-11. PubMed ID: 7236153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
    Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
    Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
    Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.